Clinical Trial
doi: 10.1159/000251310.
Topical treatment with urea-hydrocortisone in atopic dermatitis. A controlled study against betamethasone 17-valerate
- PMID: 1107090
- DOI: 10.1159/000251310
Item in Clipboard
Clinical Trial
Topical treatment with urea-hydrocortisone in atopic dermatitis. A controlled study against betamethasone 17-valerate
Dermatologica.
1975.
Abstract
When comparing 1% hydrocortisone in a stabilized 10% urea cream with 0.1% betamethasone 17-valerate cream in a double-blind study on 49 patients with atopic dermatitis or atopic winter feet, betamethasone cream was found to be the most potent. The study also showed that in approximately 60% of the patients the clinical response was equal. It is suggested that the urea-hydrocortisone combination may have its place in the long-term topical treatment of atopic dermatitis on account of its water-binding effect.
Similar articles
-
Comparison of a modified hydrocortisone/urea cream and betamethasone valerate cream in the treatment of dry eczema.J Int Med Res. 1987 Mar-Apr;15(2):99-105. doi: 10.1177/030006058701500207. J Int Med Res. 1987. PMID: 3582724 Clinical Trial.
-
A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses.Curr Med Res Opin. 1977-1978;5(4):354-8. doi: 10.1185/03007997709110192. Curr Med Res Opin. 1977. PMID: 343995 Clinical Trial.
-
Halomethasone (C 48.401-Ba) for the topical treatment of common dermatoses.J Int Med Res. 1984;12(5):307-9. doi: 10.1177/030006058401200508. J Int Med Res. 1984. PMID: 6238861 Clinical Trial.
-
Topical glucocorticoids with improved benefit/risk ratio: do they exist?J Am Acad Dermatol. 1992 Jul;27(1):87-92. doi: 10.1016/0190-9622(92)70162-9. J Am Acad Dermatol. 1992. PMID: 1619082 Review.
-
Current management and future trends in atopic eczema (A.E.).Ir Med J. 1995 Jul-Aug;88(4):110, 112. Ir Med J. 1995. PMID: 7672939 Review. No abstract available.